Anthropic Expands AI for Science Program with New Research Grants
Anthropic has launched an initiative offering free API credits to researchers in biology and life sciences, supporting projects that aim to accelerate discovery through advanced AI tools like Claude Science. The program includes tiered funding and excludes certain regions due to export controls.
TL;DR: Anthropic launched its expanded AI for Science initiative, offering free API credits to researchers in biology and life sciences to accelerate discovery through tools like Claude Science. This strategic move positions Anthropic alongside major tech firms investing in healthcare while excluding regions under U.S. export controls.
Key facts
- Anthropic launched an expanded ‘AI for Science’ initiative offering free API credits to researchers in biology and life sciences at academic or nonprofit institutions.
- The program centers on ‘Claude Science,’ an AI-powered workbench introduced in late 2023 that integrates tools like PubMed and Jupyter notebooks into a unified environment.
- Applications are reviewed monthly, with one cycle citing a final deadline of July 15, 2026; funding tiers may include amounts such as $20,000 or $50,000.
- In June 2026, Anthropic announced an internal drug discovery initiative targeting neglected diseases to create feedback loops for refining its AI models.
- Eligibility excludes residents of countries subject to U.S. export controls, including Russia, China, Iran, North Korea, Cuba, Myanmar, Sudan, and Syria.
Anthropic Unveils Expanded AI for Science Initiative
Anthropic has launched an expanded program to support scientific research using artificial intelligence, focusing on high-impact projects in biology and life sciences. The initiative provides free access to API credits for qualified researchers at academic or nonprofit institutions, aiming to accelerate discovery by enabling faster data analysis, hypothesis generation, experiment design, and clearer communication of results [1].
Claude Science: An Integrated Research Workbench
At the core of this effort is ‘Claude Science,’ an AI-powered workbench introduced in late 2023. This tool brings together commonly used research platforms—such as PubMed for literature review and Jupyter notebooks for data analysis—into a unified environment where scientists can conduct experiments, draft manuscripts, and track progress with auditable records [3]. The platform is designed to streamline workflows and reduce the time spent switching between tools.
Funding Tiers and Application Process
Researchers applying through the AI for Science Program may receive API credits based on their project’s scope and potential impact. While specific funding amounts like $20,000 or $50,000 have been referenced in some materials [6], these figures are not confirmed by primary sources and should be treated as illustrative rather than definitive. The program reviews applications monthly, with one cycle noted to have a final deadline of July 15, 2026 [4][5].
Internal Drug Discovery Efforts
In June 2026, Anthropic announced an internal drug discovery initiative focused on diseases that are often overlooked by traditional pharmaceutical companies—commonly referred to as ‘neglected’ diseases. This effort is intended to create real-world feedback loops for refining AI models and tools, with the goal of improving future iterations of its systems [2].
Eligibility and Restrictions
The program excludes individuals residing in countries subject to U.S. export controls, including Russia, China, Iran, North Korea, Cuba, Myanmar, Sudan, Syria, Crimea, and certain regions in Ukraine [4]. Employees of Anthropic, their immediate families, and those directly involved in administering the program are also ineligible to receive credits [4].
Importantly, participants do not gain access to non-standard or private models, nor are they exempt from Anthropic’s standard usage policies [6]. The company emphasizes that this is a grant program to support research, not a product development partnership.
Strategic Positioning in Life Sciences
Anthropic’s move places it among major technology firms—including Alphabet (Google), Apple, and Amazon—that have increasingly invested in healthcare and life sciences. These companies are leveraging AI to tackle challenges from drug discovery to clinical decision support [2][7]. By focusing on underserved areas and supporting open scientific collaboration, Anthropic aims to differentiate its approach within the growing field of AI for science.
The initiative reflects a broader trend where AI is no longer just a computational tool but an active collaborator in the research process—assisting scientists not only with data crunching but also with creative problem-solving and experimental planning.
Sources
- Introducing Anthropic’s AI for Science Program (www.anthropic.com) — 2023-11-03
- Claude Science, an AI workbench for scientists (www.anthropic.com) — 2023-11-03
- Anthropic’s AI for Science Program | Anthropic Help Center (support.claude.com) — 2026-03-16
- Anthropic’s AI for Science Program Official Rules (www.anthropic.com) — 2026-08-25
- AI for Science Program by Anthropic | Atom Grants (atomgrants.com) — 2026-04-11
- Anthropic launches AI drug discovery program, joining tech giants in betting on healthcare (www.cnbc.com) — 2026-06-30
- Tech giants plunge into life sciences - Nature Biotechnology (www.nature.com) — 2026-08-11